InsidersTradesSigma
Browse the complete record of transactions filed by David Liberg, Membre du Conseil. Officer active across 2 companies, notably Cantargia AB. Aggregated, 3 reports have been published. History available since 29 August 2025. The latest transaction was filed on 30 March 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
David Liberg is a board member of Cantargia AB. He contributes to the strategic direction of the company, which focuses on developing innovative treatments for cancer. His experience in biotechnology and commitment to innovation are valuable assets for the company.